Quercis Pharma

Biopharma, Biotechnology, Life Science, Medical, Pharmaceutical
Founded in 1/1/19
Zug, Zug, Switzerland
http://www.quercis.com/
For Profit

About Quercis Pharma

Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases. It is advancing a development pipeline of late-stage clinical studies that focus on the prevention of VTE in cancer patients. In addition, Quercis targets other diseases associated with thrombotic events, such as sickle cell disease (SCD), Ebola, and COVID-19. The Company’s lead drug candidate acts as an antithrombotic with a significantly lower risk of adverse events than existing treatments. The company was founded in 2019 and is based in Zug, Switzerland.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 150000000 USD
  • Last Funding: 150000000 USD (Private Equity)
  • Funding Status: Private Equity

Technology Stack

Quercis Pharma actively uses None products in their tech stack.

Market Presence

Industries: Biopharma, Biotechnology, Life Science, Medical, Pharmaceutical

Headquarters: Zug, Zug, Switzerland